Literature DB >> 20530265

CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Charles S Rosenberg1, Dianya L Martin, Rick L Tarleton.   

Abstract

CD8(+) T cells are essential for controlling Trypanosoma cruzi infection. During Brazil strain infection, C57BL/6 mice expand parasite-specific CD8(+) T cells recognizing the dominant TSKB20 (ANYKFTLV) and subdominant TSKB74 (VNYDFTLV) trans-sialidase gene (TS)-encoded epitopes with up to 40% of all CD8(+) T cells specific for these epitopes. Although this is one of the largest immunodominant T cell responses described for any infection, most mice fail to clear T. cruzi and subsequently develop chronic disease. To determine if immunodominant TS-specific CD8(+) T cells are necessary for resistance to infection, we epitope-tolerized mice by high-dose i.v. injections of TSKB20 or TSKB74 peptides. Tolerance induction led to deletion of TS-specific CD8(+) T cells but did not prevent the expansion of other effector CD8(+) T cell populations. Mice tolerized against either TSKB20 or TSKB74, or both epitopes simultaneously, exhibited transient increases in parasite loads, although ultimately they controlled the acute infection. Furthermore, BALB/c mice tolerized against the TSKD14 peptide effectively controlled acute T. cruzi infection. These data are consistent with the hypothesis that development of high-frequency CD8(+) T cell populations focused on TS-derived epitopes contributes to optimal control of acute infection but is not required for the development of immune resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530265      PMCID: PMC3784248          DOI: 10.4049/jimmunol.1000432

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation.

Authors:  Robbert G van der Most; Kaja Murali-Krishna; J Gibson Lanier; E John Wherry; Maryann T Puglielli; Joseph N Blattman; Alessandro Sette; Rafi Ahmed
Journal:  Virology       Date:  2003-10-10       Impact factor: 3.616

Review 2.  Antigenic variation in Trypanosoma brucei: facts, challenges and mysteries.

Authors:  Etienne Pays; Luc Vanhamme; David Pérez-Morga
Journal:  Curr Opin Microbiol       Date:  2004-08       Impact factor: 7.934

3.  Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.

Authors:  R L Tarleton
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

4.  Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.

Authors:  Daniel F Hoft; Christopher S Eickhoff; Olivia K Giddings; José R C Vasconcelos; Maurício M Rodrigues
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

5.  Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide.

Authors:  Yanice V Mendez-Fernandez; Aaron J Johnson; Moses Rodriguez; Larry R Pease
Journal:  Eur J Immunol       Date:  2003-09       Impact factor: 5.532

Review 6.  Immune responses to Listeria monocytogenes.

Authors:  Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

7.  Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.

Authors:  Denise L Doolan; Scott Southwood; Daniel A Freilich; John Sidney; Norma L Graber; Lori Shatney; Lolita Bebris; Laurence Florens; Carlota Dobano; Adam A Witney; Ettore Appella; Stephen L Hoffman; John R Yates; Daniel J Carucci; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

8.  Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.

Authors:  Filipe A Haolla; Carla Claser; Bruna C G de Alencar; Fanny Tzelepis; José Ronnie de Vasconcelos; Gabriel de Oliveira; Jaline C Silvério; Alexandre V Machado; Joseli Lannes-Vieira; Oscar Bruna-Romero; Ricardo T Gazzinelli; Ricardo Ribeiro dos Santos; Milena B P Soares; Mauricio M Rodrigues
Journal:  Vaccine       Date:  2009-07-25       Impact factor: 3.641

Review 9.  Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens.

Authors:  Kirk W Deitsch; Sheila A Lukehart; James R Stringer
Journal:  Nat Rev Microbiol       Date:  2009-06-08       Impact factor: 60.633

Review 10.  Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.

Authors:  Diana Martin; Rick Tarleton
Journal:  Immunol Rev       Date:  2004-10       Impact factor: 12.988

View more
  31 in total

1.  Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities.

Authors:  Chek Meng Poh; Shanshan W Howland; Gijsbert M Grotenbreg; Laurent Rénia
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.

Authors:  Charles S Rosenberg; Weibo Zhang; Juan M Bustamante; Rick L Tarleton
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

Review 3.  CD8+ T cells in Trypanosoma cruzi infection.

Authors:  Rick L Tarleton
Journal:  Semin Immunopathol       Date:  2015-04-29       Impact factor: 9.623

4.  An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.

Authors:  Christopher S Eickhoff; Daniel Van Aartsen; Frances E Terry; Sheba K Meymandi; Mahmoud M Traina; Salvador Hernandez; William D Martin; Leonard Moise; Annie S De Groot; Daniel F Hoft
Journal:  Hum Vaccin Immunother       Date:  2015-06-24       Impact factor: 3.452

Review 5.  Understanding CD8+ T Cell Immunity to Trypanosoma cruzi and How to Improve It.

Authors:  Eva V Acosta Rodríguez; Cintia L Araujo Furlan; Facundo Fiocca Vernengo; Carolina L Montes; Adriana Gruppi
Journal:  Trends Parasitol       Date:  2019-10-10

Review 6.  Advances and challenges towards a vaccine against Chagas disease.

Authors:  Israel Quijano-Hernandez; Eric Dumonteil
Journal:  Hum Vaccin       Date:  2011-11-01

7.  The Trypanosoma cruzi flagellum is discarded via asymmetric cell division following invasion and provides early targets for protective CD8⁺ T cells.

Authors:  Samarchith P Kurup; Rick L Tarleton
Journal:  Cell Host Microbe       Date:  2014-10-08       Impact factor: 21.023

8.  Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.

Authors:  Nicole L Sullivan; Christopher S Eickhoff; John Sagartz; Daniel F Hoft
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

9.  Engineering the PP7 Virus Capsid as a Peptide Display Platform.

Authors:  Liangjun Zhao; Mykhailo Kopylov; Clinton S Potter; Bridget Carragher; M G Finn
Journal:  ACS Nano       Date:  2019-03-26       Impact factor: 15.881

Review 10.  Immune response and immunopathology during toxoplasmosis.

Authors:  Christopher D Dupont; David A Christian; Christopher A Hunter
Journal:  Semin Immunopathol       Date:  2012-09-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.